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The histone lysine demethylaseKDM4C is often over-
expressed in cancers primarily through gene amplifi-
cation. The molecular mechanisms of KDM4C action
in tumorigenesis are not well defined. Here, we report
that KDM4C transcriptionally activates amino acid
biosynthesis and transport, leading to a significant
increase in intracellular amino acid levels. Examina-
tion of the serine-glycine synthesis pathway reveals
that KDM4C epigenetically activates the pathway
genesundersteady-stateandserinedeprivationcon-
ditions by removing the repressive histone modifica-
tion H3 lysine 9 (H3K9) trimethylation. This action of
KDM4C requires ATF4, a transcriptional master regu-
lator of amino acidmetabolismand stress responses.
KDM4C activates ATF4 transcription and interacts
with ATF4 to target serine pathway genes for tran-
scriptional activation. We further present evidence
for KDM4C in transcriptional coordination of amino
acidmetabolismandcell proliferation. These findings
suggest a molecular mechanism linking KDM4C-
mediated H3K9 demethylation and ATF4-mediated
transactivation in reprogramming amino acid meta-
bolism for cancer cell proliferation.INTRODUCTION
Histone lysine methyltransferases (KMTs) and demethylases
(KDMs) have a central role in regulation of transcription by
controlling the state of histone lysine methylation. KMTs use
S-adenosylmethionine (SAM) as the methyl group donor, while506 Cell Reports 14, 506–519, January 26, 2016 ª2016 The AuthorsKDM1 and KDM2-KDM8 family members require flavin adenine
dinucleotide (FAD) and a-ketoglutarate (a-KG) for demethylation,
respectively (Black et al., 2012; Mosammaparast and Shi, 2010).
The dependence of KMTs and KDMs on metabolic coenzymes
suggests that their activities are sensitive to changes in cell
metabolism, a model supported by a compelling body of evi-
dence from recent studies (Gut and Verdin, 2013; Kaelin and
McKnight, 2013; Katada et al., 2012; Lu and Thompson, 2012;
Lu et al., 2012; Shyh-Chang et al., 2013; Teperino et al., 2010).
This notion also suggests that, based on the principle of feed-
back control, KMTs and KDMs must reciprocally influence cell
metabolism through transcriptional regulation of metabolic en-
zymes (Teperino et al., 2010) (Figure S1A).
Cancer cell growth and proliferation require enhanced meta-
bolic capacity for accumulation of biomass and replication of
the genomic DNA (Cairns et al., 2011; DeBerardinis et al.,
2008; Vander Heiden et al., 2009). Increased activation of the
serine-glycine synthesis pathway (herein referred to as the serine
pathway) through genetic (Locasale et al., 2011; Possemato
et al., 2011) and epigenetic (Ding et al., 2013) mechanisms
has been observed in several cancer types. In addition, recent
studies have provided evidence for a key role of serine uptake
in sustaining the proliferation of cancer cells (Jain et al., 2012;
Labuschagne et al., 2014; Maddocks et al., 2013). The serine
pathway is composed of phosphoglycerate dehydrogenase
(PHGDH), phosphoserine aminotransferase 1 (PSAT1), phos-
phoserine phosphatase (PSPH), and serine hydroxymethyltrans-
ferase (SHMT). This pathway generates biosynthetic precursors
essential for the production of proteins, nucleic acids, fatty
acids, and the membranes needed for cell proliferation (Amelio
et al., 2014; DeBerardinis, 2011; Kalhan and Hanson, 2012;
Locasale, 2013) (Figure S1B). More recently, it has been shown
that serine-driven one-carbon metabolism is a major pathway
of NADPH production in proliferating cells, with oxidation of
5,10-methylene-tetrahydrofolate to 10-formyl-tetrahydrofolate
being coupled to reduction of NADP+ to NADPH (Fan et al.,
2014). NADPH is required for reductive biosynthesis, such as
the synthesis of nucleotides, amino acids and lipids, and has
a pivotal role in maintaining the cellular redox balance (Schulze
and Harris, 2012). Also, cancer cells can uptake exogenous
serine for the production of glycine and one-carbon units through
the final step of the serine pathway catalyzed by SHMT (Labu-
schagne et al., 2014) (Figure S1B). Thus, a better understanding
of the function and regulation of the serine pathway might
suggest new therapeutic approaches for inhibiting cancer meta-
bolism and blocking cancer growth (Chaneton et al., 2012; Mad-
docks et al., 2013).
We recently identified a G9A-dependent epigenetic mecha-
nism for transcriptional activation of the serine pathway in cancer
cells (Ding et al., 2013). G9A, also known as EHMT2 and KMT1C,
is a H3K9 methyltransferase that has a primary role in catalyzing
H3K9me1 and H3K9me2 in euchromatin (Shinkai and Tachi-
bana, 2011), with H3K9me1 being associated with active chro-
matin and H3K9me2 being a repressive mark (Black et al.,
2012; Mosammaparast and Shi, 2010). We found that G9A is
required for maintaining the serine pathway genes in an active
state and for transcriptional activation of this pathway in
response to serine deprivation. Moreover, higher G9A expres-
sion significantly increases serine and glycine biosynthesis in
the cell. These findings provide direct evidence for transcrip-
tional reprograming of cell metabolism by a KMT.
An implication of the G9A study is that H3K9 methylation
states control the transcription of serine pathway genes. This
led us to hypothesize that KDMs that target H3K9 may also
play a role in transcriptional regulation of the serine pathway.
Multiple KDMs catalyze the removal of methyl groups at H3K9:
KDM3B can remove all methyl groups (me1-3); KDM4 only
me2 and me3; and KDM3A and KDM7A-B only me1 and me2
(Black et al., 2012; Mosammaparast and Shi, 2010). Thus, the
KDM4 family of demethylases could transcriptionally activate
serine pathway genes by removing the repressive marks
H3K9me2 and H3K9me3 at their loci. We focused our study
on KDM4C, also known as JMJD2C, primarily because of the
strong evidence for an important role of KDM4C in cancer devel-
opment (Berry and Janknecht, 2013; Labbe´ et al., 2013). The
KDM4C gene is located in chromosome 9p24, which is ampli-
fied in various cancer types, including lymphoma, breast
cancer, esophageal squamous cell carcinoma, lung sarcoma-
toid carcinoma, and medulloblastoma (Berdel et al., 2012;
Cloos et al., 2006; Ehrbrecht et al., 2006; Italiano et al., 2006;
Liu et al., 2009; Northcott et al., 2009; Rui et al., 2010; Vinatzer
et al., 2008; Wu et al., 2012; Yang et al., 2000). Our study reveals
that KDM4C has a general role in transcriptional activation
of amino acid biosynthesis and transport, including serine and
glycine. These findings provide evidence for the ability of
KDMs to reprogram amino acid metabolism in cancer cells.
RESULTS
KDM4C Is Essential for the Expression of Serine
Pathway Genes and Cancer Cell Proliferation
As an initial step to assess the role of KDM4C in transcriptional
control of the serine pathway, we analyzed the published datasetCGEO: GSE28332 from a recent chromatin immunoprecipitation
and sequencing (ChIP-seq) study of genome-wide KDM4Cbind-
ing sites (Pedersen et al., 2014). The analysis revealed specific
association of KDM4C with the promoters of serine pathway
genes, including PHGDH and PSAT1 (Figure 1A), in KYSE150
cells, a human esophageal squamous cell carcinoma cell line.
Interestingly, ChIP-seq data from the same study also showed
the binding of Kdm4c (Jmjd2c) to the Phgdh and Psat1 pro-
moters in mouse embryonic stem cells but not fibroblasts
(Figure S1C), suggesting a specific role of KDM4C in regulation
of serine pathway genes in cells with unlimited proliferative
potential.
Next, we determined whether KDM4C is required for tran-
scription of serine pathway genes in human cancer cell lines by
silencing KDM4C with small hairpin RNA (shRNA). We identified
two independent shRNA constructs (shKDM4C-54 and -58)
that were highly effective in knockdown of KDM4C expression
(Figures S2A and S2B) but showed no significant effect on
the expression of other KDM4 family members (Figure S2B).
Immunofluorescence staining showed that KDM4C knockdown
resulted in a significant increase in H3K9me3 levels (Figures
S2C and S2D). Consistent with the ChIP-seq finding (Figure 1A),
ChIP and qPCR (ChIP-qPCR) revealed significant levels of
KDM4C at the promoters of PHGDH and PSAT1 in neuro-
blastoma BE(2)-C cells (Figure 1B, shGFP). KDM4C knock-
down markedly decreased KDM4C levels at these promoters
(Figure 1B, shKDM4C-58), with a corresponding increase in
H3K9me3, but not H3K9me2, levels (Figure 1C). As a control,
we observed no significant binding of KDM4C to the promoter
of HOXC9 (Figure 1B), a gene involved in neuroblastoma differ-
entiation (Mao et al., 2011; Wang et al., 2013).
In agreement with the ChIP-qPCR results, quantitative reverse
transcriptase-PCR (qRT-PCR) showed that KDM4C knockdown
significantly repressed the transcription of serine pathway
genes, but not that of HOXC9 (Figures 1D, left and middle, and
S2E), leading to a marked reduction in PHGDH and PSAT1 pro-
tein levels (Figure 1E). Also, as reported previously (Ding et al.,
2013), G9A knockdown significantly reduced mRNA expression
of serine pathway genes (Figure 1D, right). Thus, similar to G9A,
KDM4C contributes to themaintenance of serine pathway genes
in an epigenetically active state for transcription.
In addition, in all the cancer cell lines examined, we observed a
pronounced inhibitory effect of KDM4C silencing on cell prolifer-
ation in culture (Figures 1F, S2F, and S2G) and in soft agar (Fig-
ures 1G and 1H). These findings are in line with recent studies
from other groups (Cloos et al., 2006; Gregory and Cheung,
2014; Kim et al., 2014; Pedersen et al., 2014), indicating a general
role of KDM4C in sustaining proliferation. Supplemental serine
and glycine failed to rescue KDM4C knockdown cells (data not
shown), suggesting additional defects in these cells that block
proliferation.
Ectopic KDM4C Expression Transcriptionally Activates
the Serine Pathway and Promotes Cancer Cell
Proliferation
As noted earlier, the KDM4C gene is amplified in various cancer
types, leading to elevated levels of KDM4C expression. We
therefore investigated the effect of high KDM4C expression onell Reports 14, 506–519, January 26, 2016 ª2016 The Authors 507
Figure 1. KDM4C Is Essential for Transcriptional Activation of the Serine Pathway and Cell Proliferation
(A)ChIP-seq tagprofiles forKDM4C levelsat thePHGDHandPSAT1promoters inKYSE150cells expressingcontrol (shCtrl) orKDM4CshRNA (shKDM4C).Horizontal
bars represent chromatin regions with significant changes in KDM4C levels (shCtrl/shKDM4C). The ChIP-seq dataset GEO: GSE28332 was used for the analysis.
(B andC) ChIP-qPCR analysis of KDM4C (B), H3K9me2 andH3K9me3 (C) levels at thePHGDH,PSAT1 andHOXC9 promoters in BE(2)-C cells expressing shRNA
to GFP (shGFP) or KDM4C (shKDM4C). Error bars represent SD (n = 3) and are representative of two independent experiments.
(D) qRT-PCR analysis of mRNA expression of serine pathway genes and HOXC9 in the indicated cell lines expressing shGFP, shKDM4C, or shG9A. Error bars
represent SD (n = 3).
(E) Immunoblotting of KDM4C, PHGDH, and PSAT1 in SHEP1 and HeLa cells expressing shGFP or shKDM4C. KDM4C, PHGDH and PSAT1 levels were
quantified against b-actin.
(F) Growth assay of the indicated cell lines expressing shGFP or shKDM4C. Error bars represent SD (n = 4). Data were analyzed by two-way ANOVAwith p values
indicated.
(G and H) Soft agar assay of BE(2)-C and SK-N-DZ cells expressing shGFP or shKDM4C. The image (G) is representative of three independent experiments with
BE(2)-C cells. Colonies were counted (H), with error bars indicating SD (n = 3).
Unless indicated, all data were analyzed with two-tailed Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figures S1 and S2.
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serine pathway gene expression using an inducible system. After
induction, KDM4C levels in these inducible cell lines were well
within the range as those seen in human neuroblastoma cell
lines (Figure S3A), indicating that the expression levels are
biologically relevant. Induction of KDM4C in BE(2)-C, HeLa,
and U2OS cells led to significantly decreased H3K9me3 levels,
accompanied by a marked increase in H3K9me1 levels (Figures
S3B–S3E). We observed no significant changes in H3K9me2
levels (Figures S3B–S3E). Moreover, ChIP-qPCR revealed signif-
icantly higher levels of KDM4C associated with the promoters of
PHGDH and PSAT1 following KDM4C induction (Figure 2A), with
a corresponding reduction in H3K9me3 levels (Figure 2B) and
a significant increase in the ratio of H3K9me1 to H3K9me3
(Figure 2C).
In agreement with the ChIP-qPCR results, KDM4C over-
expression alone was sufficient to transcriptionally activate
serine pathway genes (Figure 2D), leading to a significant in-
crease in PHGDH and PSAT1 protein levels (Figure 2E). Impor-
tantly, the ability of KDM4C to transcriptionally activate serine
pathway genes depends on its demethylase activity, since
overexpression of KDM4C-Ser198Met (S198M), a catalytic
inactive KDM4C mutant (Kupershmit et al., 2014), was unable
to upregulate PHGDH and PSAT1 (Figure 2F). Together, these
results indicate that KDM4C directly targets serine pathway
genes for transcriptional activation by conferring an epige-
netically active state with decreased H3K9me3 and increased
H3K9me1 levels.
In linewith recent studies from other groups (Cloos et al., 2006;
Gregory and Cheung, 2014; Kim et al., 2014; Pedersen et al.,
2014), KDM4C induction in various cancer cell lines markedly
enhanced cell proliferation (Figure 2G) and tumorigenicity (Fig-
ures 2H and 2I). Knockdown of PHGDH expression by shRNA
largely abolished the proliferation-enhancing activity of KDM4C
(Figures 2J and 2K). These findings are consistent with themodel
that the serine pathway is a key downstream target of KDM4C
in promoting cell proliferation.
KDM4CHas a General Role in Transcriptional Activation
of Amino Acid Biosynthesis and Transport
To better understand the molecular mechanism of KDM4C
action, we performed microarray gene expression profiling of
BE(2)-C cells before and after KDM4C induction. A total of 401
KDM4C-responsive genes (R±1.40-fold, p < 0.05) were identi-
fied, with 250 genes being upregulated and 151 downregulated
(Table S1). Consistent with the data presented above, gene
ontology (GO) analysis revealed that genes upregulated by
KDM4C are highly enriched for GO terms associated with
biosynthesis and metabolism of the serine family of amino acids
(Figure 3A; Table S2). In addition, GO analysis suggests a role of
KDM4C in transcriptional activation of amino acid transport,
the unfolded protein response and chromatin assembly (Fig-
ure 3A; Table S2). PANTHER (Protein ANalysis THrough Evolu-
tionary Relationships) analysis, which examines evolutionary
sequence-function relationships (Thomas et al., 2003), further
revealed a general role of KDM4C in the control of amino acid
transport and biosynthesis (Figure 3B; Table S2). We found no
significant effect of KDM4C on other major metabolic path-
ways including glycolysis and the tricarboxylic acid (TCA) cycleC(Tables S1 and S2), suggesting a specific function of KDM4C
in regulation of amino acid metabolism.
We confirmed the microarray data by qRT-PCR. In addition to
serine pathway genes, KDM4C significantly upregulated mRNA
expression of genes encoding asparagine synthetase (ASNS),
argininosuccinate synthase 1 (ASS1), cystathionine gamma-
lyase (CTH), glutamic-oxaloacetic transaminase 1 (GOT1, also
known as aspartate aminotransferase), and glutamic pyruvate
transaminase 2 (GPT2) (Figure 3C). These enzymes are involved
in the biosynthesis of alanine, arginine, asparagine, aspartic
acid, cysteine, and glutamic acid. We also confirmed by qRT-
PCR that KDM4C induced mRNA expression of SLC1A4,
SLC1A5, SLC3A2, SLC6A9, SLC7A1, SLC7A5, and SLC7A11,
but not that of SLC38A2 (Figure 3D). These proteins are involved
in the transport of all amino acids except aspartic acid, aspara-
gine, and proline (Hyde et al., 2003). These results, coupled to
the observation that KDM4C binds to many of these gene pro-
moters (Figure S4), suggest that KDM4C directly targets these
genes for transcriptional activation.
In support of the gene expression data, gas chromatography-
mass spectrometry (GC-MS) analysis revealed that KDM4C
induction markedly elevated the intracellular levels of 15 amino
acids (Figure 3E). In addition, there was a significant increase
in the kinase activity of the mechanistic target of rapamycin
complex 1 (mTORC1) as demonstrated by increased phosphor-
ylation of the ribosome protein S6 kinase (S6K) (Figure 3F), a
key mTORC1 substrate. Importantly, the ability of KDM4C to
promote cell proliferation was completely abrogated by rapamy-
cin, an inhibitor of mTORC1 (Figure 3G). It is known that elevated
levels of amino acids activate mTORC1, which in turn promotes
cell growth and proliferation by stimulating macromolecule
biosynthesis and cell-cycle progression (Kim and Guan, 2011;
Laplante and Sabatini, 2012). These findings link KDM4C to
the activation of amino acid-mTORC1 signaling, which may
contribute to KDM4C-induced proliferation.
KDM4C Links Amino Acid Metabolism to Cell Cycle
Progression
It has been shown recently that KDM4C transcriptionally acti-
vates the expression of genes that promote cell-cycle progres-
sion, such as CCNB1 and MYBL2 (Pedersen et al., 2014) (see
also Figure S5). In line with this finding, gene set enrichment
analysis (GSEA) of our microarray data revealed that KDM4C
induction led to higher expression of a large number of cell-cycle
genes including those critical for M phase progression (Figures
4A and 4B). Particularly interesting is the observation that most
of the Forkhead box protein M1 (FOXM1) pathway genes were
transcriptionally activated (Figures 4C and 4D). We confirmed
the microarray data by qRT-PCR, which showed that KDM4C
significantly increased mRNA expression of CCNB1, CCNE1,
CDK2, FOXM1, and MYBL2, but not that of CCND1 (Figure 4E).
MYBL2 and FOXM1 are transcription factors that have an
essential role in coordinating the expression of cell-cycle genes
required for S and M phase progression, respectively (Sadasi-
vam and DeCaprio, 2013). These findings, together with those
presented above, suggest a KDM4C-dependent epigenetic
mechanism in transcriptional coordination of amino acid meta-
bolism and proliferation in cancer cells.ell Reports 14, 506–519, January 26, 2016 ª2016 The Authors 509
Figure 2. KDM4C Transcriptionally Activates the Serine Pathway and Promotes Proliferation and Tumorigenicity
(A–C) ChIP-qPCR analysis of the levels of KDM4C (A), H3K9me2 and H3K9me3 (B), and the ratio H3K9me1 to H3K9me3 (C) at the PHGDH, PSAT1, and HOXC9
promoters in BE(2)-C cells with inducible KDM4C expression. Error bars represent SD (n = 3) and are representative of two independent experiments.
(D) qRT-PCR analysis of mRNA levels of serine pathway genes and HOXC9 in BE(2)-C and HeLa cells with inducible KDM4C expression. Error bars represent SD
(n = 3).
(E and F) Immunoblotting of KDM4C, PHGDH, and PSAT1 in the indicated cell lines with inducible KDM4C expression (E) and in HeLa cells transfected with
plasmids expressing GFP, wild-type KDM4C, or catalytic inactivemutant KDM4C S198M (F). KDM4C, PHGDH, and PSAT1 levels were quantified against b-actin
(E) or a-tubulin (F).
(G) Growth assay of the indicated cell lines with inducible KDM4C expression. Error bars represent SD (n = 4). Data were analyzed by two-way ANOVA with
p values indicated.
(H and I) Xenograft assay of BE(2)-C cells with inducible expression of GFP or KDM4C. Tumor weight (I) was analyzed by scatterplot with horizontal lines indicating
the mean.
(J) Immunoblotting of PHGDH in HeLa_tetoff_KDM4C cells expressing shGFP or shPHGDH. b-actin levels are shown as loading control.
(K) Growth assay of HeLa cells with or without KDM4C induction and PHGDH knockdown (n = 4). Data were analyzed by two-way ANOVAwith p values indicated.
***p < 0.001. See also Figure S3.
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Figure 3. KDM4C Transcriptionally Activates Amino Acid Biosynthesis and Transport
(A and B) GO and PANTHER analyses of genes upregulated by KDM4C in BE(2)-C cells. Shown are top 10 GO (A) and PANTHER (B) biological process terms
based on fold enrichment.
(C and D) qRT-PCR analysis of amino acid biosynthesis (C) and transporter (D) genes induced by KDM4C. Error bars represent SD (n = 3).
(E) GC-MS analysis of amino acid levels in BE(2)-C_tetoff_KDM4C cells with or without doxycycline for 6 days. Error bars represent SD (n = 5).
(F) Immunoblotting of KDM4C, S6K and pS6K (T389) in BE(2)-C and HeLa cells with or without KDM4C induction. a-tubulin levels are shown as loading control.
(G) Growth assay of BE(2)-C cells with or without KDM4C induction and 10 nM Rapamycin (rapa). Error bars represent SD (n = 4).
**p < 0.01, ***p < 0.001. See also Figure S4 and Tables S1 and S2.KDM4C IsRequired for the SerineDeprivation Response
Our GSEA of the microarray data also showed that KDM4C
upregulated most of the genes involved in the amino acid depri-
vation response, including ASNS, ATF3, DDIT3 (also known as
CHOP), and TRIB3 (Figures 5A and S6A), which was confirmedCby qRT-PCR (Figure 5B). Moreover, our analysis of the ChIP-
seq dataset GEO: GSE28332 showed specific association of
KDM4C with the promoters of ASNS (Figure S4A), ATF3 and
DDIT3 (Figure S6B), suggesting that they are direct target genes
of KDM4C.ell Reports 14, 506–519, January 26, 2016 ª2016 The Authors 511
Figure 4. KDM4C Induces Late Cell-Cycle
Genes
(A–D) GSEA shows significant enrichment of gene
sets involved in the cell cycle (A), M phase (B), and
the FOXM1 pathway (C and D), with most of the
genes being upregulated by KDM4C.
(E) qRT-PCR analysis of mRNA levels of cell-cycle
genes in BE(2)-C cells with or without KDM4C
induction. Error bars represent SD (n = 3). **p <
0.01, ***p < 0.001.
See also Figure S5 and Table S1.These observations also provided us with an experimental
system for investigating whether KDM4C has a physiological
function in transcriptional control of amino acid metabolism.
It is known that serine deprivation leads to transcriptional acti-
vation of the serine pathway (Ding et al., 2013; Maddocks
et al., 2013; Ye et al., 2012). As expected, serine removal
from the culture media resulted in elevated mRNA expression
of serine pathway genes, as well as ASNS, ATF3, DDIT3,
and TRIB3 (Figures 5C and 5D, shGFP). Knockdown of
KDM4C expression largely abrogated the serine deprivation
response at the transcriptional level (Figures 5C and 5D,
shKDM4C). Consistent with the qRT-PCR results, serine depri-
vation markedly increased KDM4C levels at the PHGDH and
PSAT1 promoters (Figure 5E), which was accompanied by a
significant reduction in H3K9me3 levels (Figure 5F). Together,
these results indicate that KDM4C epigenetically activates
transcription of serine pathway genes in response to serine
deprivation.
ATF4 Is a Direct Transcriptional Target of KDM4C
Activating Transcription Factor 4 (ATF4) has a key role in the
amino acid deprivation response (Ameri and Harris, 2008;
Kilberg et al., 2009). We found that knockdown of KDM4C
expression led to a marked reduction in ATF4 expression
at both mRNA and protein levels (Figures 6A and 6B), indi-
cating an essential role of KDM4C in maintaining the basal
level of ATF4 expression. Conversely, KDM4C overexpression
robustly induced ATF4 at both mRNA and protein levels (Fig-
ures 6C and 6D). Examination of the ChIP-seq dataset GEO:
GSE28332 revealed that KDM4C specifically binds to the
ATF4 promoter (Figure S6B, ATF4). The finding was confirmed
by ChIP-qPCR assay, which showed that KDM4C overexpres-512 Cell Reports 14, 506–519, January 26, 2016 ª2016 The Authorssion significantly increased the level
of KDM4C at the ATF4 promoter (Fig-
ure 6E), with a corresponding increase
in the ratio of H3K9me1 to H3K9me3
(Figure 6F). Collectively, these results
indicate that ATF4 is a direct target
gene of KDM4C.
Next, we investigated whether KDM4C
has a physiological function in transcrip-
tional control of ATF4 expression. It is
known that ATF4 expression is markedly
increased following amino acid depriva-
tion, as a result of both transactivation
of its gene and stabilization of its pro-tein (Ameri and Harris, 2008; Kilberg et al., 2009). We found
that serine deprivation significantly increased the level of
KDM4C at the ATF4 promoter, accompanied by a significant
reduction in the level of H3K9me3 (Figure 6G). As expected,
serine deprivation induced ATF4 mRNA expression (Figure 6H).
Importantly, the induction was completely abrogated by knock-
down of KDM4C expression (Figure 6I), leading to a marked
decrease in ATF4 protein levels compared to shGFP control (Fig-
ure 6J). Together, these findings identify an essential role of
KDM4C both in the maintenance of the basal level of ATF4
expression and in the transcriptional induction of ATF4 in
response to serine deprivation.
KDM4C Requires ATF4 for Transcriptional Activation of
the Serine Pathway and Amino Acid Transport
Previous studies have shown that PHGDH and PSAT1 are target
genes of ATF4 (Adams, 2007; Seo et al., 2009; Ye et al., 2012). It
is also known that ATF4 can transcriptionally upregulate amino
acid transporters (Adams, 2007). These observations suggest
that ATF4may function downstream of KDM4C in transcriptional
regulation of amino acid metabolism. In support of this hypothe-
sis, knockdown of ATF4 expression completely abrogated the
ability of KDM4C to promote cell proliferation (Figure 7A) and
to upregulate serine pathway and amino acid transporter genes
(Figures 7B and 7C). Reciprocally, ATF4 also required KDM4C
for maximal induction of serine pathway genes, as KDM4C
knockdown significantly inhibited the induction of PHGDH and
PSAT1 by ATF4 overexpression (Figure S7). Thus, KDM4C and
ATF4 cooperate, and are mutually dependent on each other, in
transcriptional regulation of amino acid metabolism.
To gain a molecular understanding of the cooperation, we
investigated the possibility that KDM4C may require ATF4 for
Figure 5. KDM4C Is Required for the Serine Deprivation Response
(A) GSEA shows significant enrichment of the gene set involved in the amino acid deprivation response, with most of the genes being upregulated by KDM4C.
(B) qRT-PCR analysis of mRNA levels of ASNS, ATF3, DDIT3, and TRIB3 in BE(2)-C and HeLa cells with inducible KDM4C expression. Error bars represent
SD (n = 3).
(C and D) qRT-PCR analysis of mRNA levels of serine pathway and amino acid deprivation response genes following serine withdrawal in SHEP1 (C) and HeLa (D)
cells expressing shGFP or shKDM4C. Error bars represent SD (n = 3).
(E and F) ChIP-qPCR analysis of KDM4C (E) and H3K9me3 (F) levels at the PHGDH, PSAT1, andHOXC9 promoters in HeLa cells in the presence (Ctrl) or absence
of serine for 6 hr. Error bars represent SD (n = 3) and are representative of two independent experiments.
**p < 0.01, ***p < 0.001. See also Figure S6 and Table S1.binding to target gene promoters. We examined the PHGDH
promoter, which was associated with high levels of KDM4C
and ATF4 following KDM4C induction (Figure 7D, shGFP).
As expected, ATF4 knockdown significantly reduced the level
of ATF4 at the PHGDH promoter (Figure 7D, anti-ATF4_
shATF4-73). Importantly, ATF4 knockdown also resulted in a
marked reduction in the level of KDM4C at the promoter
(Figure 7D, anti-KDM4C_shATF4-73), with a corresponding
increase in H3K9me3 levels (Figure 7D, anti-H3K9me3_
shATF4-73). Moreover, we found that ATF4 could be co-immu-
noprecipitated with KDM4C under the conditions of KDM4C
overexpression (Figure 7E) and serine deprivation (Figure 7F).
Together, these results demonstrate that KDM4C interacts
with and depends on ATF4 for targeting serine pathway genes
(Figure 7G).CDISCUSSION
In this report, we present evidence for cooperation between the
histone H3K9 demethylase KDM4C and the transcription factor
ATF4 in transcriptional regulation of amino acid metabolism. In
addition, we present evidence suggesting a KDM4C-dependent
epigenetic mechanism in coordinating amino acid metabolism
and cell-cycle progression. Together, these findings provide
direct evidence for metabolic reprograming by KDM4C and
shed new light on its oncogenic activity in cancer development.
KDM4C in Transcriptional Control of Amino Acid
Metabolism
Our study reveals a general role of KDM4C in transcriptional
activation of amino acid biosynthesis and transport. KDM4Cell Reports 14, 506–519, January 26, 2016 ª2016 The Authors 513
Figure 6. KDM4C Is Required for Transcriptional Activation of ATF4
(A) qRT-PCR analysis of ATF4 mRNA levels in the indicated cancer cell lines with or without KDM4C knockdown. Error bars represent SD (n = 3).
(B) Immunoblotting of ATF4 and KDM4C in HeLa and SHEP1 cells with or without KDM4C knockdown. ATF4 and KDM4C levels were quantified against b-actin.
(C) qRT-PCR analysis of ATF4 mRNA levels in BE(2)-C and HeLa cells with inducible KDM4C expression. Error bars represent SD (n = 3).
(D) Immunoblotting of ATF4 and KDM4C in BE(2)-C and HeLa cells with inducible KDM4C expression. ATF4 and KDM4C levels were quantified against b-actin.
(E and F) ChIP-qPCR analysis of KDM4C levels (E) and the ratio H3K9me1 to H3K9me3 (F) at the ATF4 promoter in BE(2)-C cells with inducible KDM4C
expression. Error bars represent SD (n = 3) and are representative of two independent experiments.
(G) ChIP-qPCR analysis of KDM4C and H3K9me3 levels at the ATF4 promoter in HeLa cells with or without serine for 6 hr. Error bars represent SD (n = 3) and are
representative of two independent experiments.
(H and I) qRT-PCR analysis of ATF4mRNA levels in HeLa and SHEP1 cells following serine withdrawal (H) and with or without KDM4C knockdown (I). Error bars
represent SD (n = 3).
(J) Immunoblotting of ATF4 and KDM4C in SHEP1 cells following serine withdrawal with or without KDM4C knockdown. ATF4 and KDM4C levels were quantified
against b-actin.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S6.overexpression transcriptionally activates the serine pathway
and several enzymes involved in the biosynthesis of alanine,
arginine, asparagine, aspartic acid, cysteine, and glutamic
acid. KDM4C can also upregulate the expression of transporters
for a majority of amino acids. As a result, cells with KDM4C over-
expression show a marked increase in the intracellular levels of
15 amino acids. Given that KDM4C is amplified or overex-
pressed in a wide range of human cancers, our findings suggest
that high KDM4C expressionmay represent an epigeneticmech-514 Cell Reports 14, 506–519, January 26, 2016 ª2016 The Authorsanism for activation of amino acid biosynthesis and transport in
cancer development.
To gain a molecular understating of KDM4C action in tran-
scriptional control of amino acid metabolism, we examined
in detail the effect of KDM4C on transcriptional regulation of
the serine pathway. Our study reveals that KDM4C is required
both for maintaining basal-level expression of the pathway
genes and for their transcriptional induction in response to serine
deprivation. KDM4C binds to the promoters of the pathway
Figure 7. KDM4C Requires ATF4 for Transcriptional Activation of Serine Pathway Genes
(A) Growth assay of BE(2)-C_ and HeLa_tetoff_KDM4C cells with or without ATF4 knockdown in the absence of doxycycline (n = 4). Data were analyzed by two-
way ANOVA with p values indicated.
(B) qRT-PCR analysis of mRNA levels of ATF4, serine pathway, and amino acid transporter genes in HeLa_tetoff_KDM4 cells in the presence or absence of
doxycycline for 7 days with or without ATF4 knockdown. Error bars represent SD (n = 3).
(C) Immunoblotting of ATF4, KDM4C, and PHGDH in HeLa_tetoff_KDM4C cells in the presence or absence of doxycycline for 7 days with or without ATF4
knockdown. ATF4 and PHGDH levels were quantified against a-tubulin.
(D) ChIP-qPCR analysis of ATF4, KDM4C and H3K9me3 levels at the PHGDH promoter in BE(2)-C_tetoff_KDM4C cells in the absence of doxycycline for 6 days
with or without ATF4 knockdown. Error bars represent SD (n = 3) and are representative of two independent experiments.
(E and F) Immunoblot analysis of coIP of KDM4C and ATF4 in extracts from BE(2)-C_tetoff_KDM4C cells in the absence of doxycycline for 6 days (E) and from
HeLa cells in serine-deficient media for 4 hr (F).
(G) Model for KDM4C-ATF4 cooperation in transactivation of serine pathway genes.
**p < 0.01, ***p < 0.001. See also Figure S7.genes and confers an epigenetically active state by removing the
repressive mark H3K9me3. Of note, most of the cell lines exam-
ined in this study also express significant levels of KDM4A and
KDM4B (data not shown). Whether they have a similar role in
serine pathway regulation remains to be defined. However,
the observed significant effect of KDM4C knockdown on the
pathway gene expression suggests that KDM4C has a non-Credundant function in maintaining the transcription state of the
serine pathway, at least in the cell lines examined.
We recently reported a G9A-dependent epigenetic program in
transcriptional activation of the serine pathway by specifically
marking the pathway genes with H3K9me1 (Ding et al., 2013).
Our findings with KDM4C provide further evidence in support of
themodel that H3K9methylation has a critical role in determiningell Reports 14, 506–519, January 26, 2016 ª2016 The Authors 515
the transcriptional state of serine pathway genes. However,
KDM4C and G9A have distinct roles in transcriptional control
of amino acid metabolism. In addition to the serine pathway,
KDM4C transcriptionally activates several amino acid synthesis
enzymes and transporters. This broad role of KDM4C in the con-
trol of amino acid metabolism might also be one of the reasons
why supplemental serine and glycine failed to rescue the prolif-
eration defect of KDM4C-knockdown cells. In contrast, G9A ap-
pears to target specifically the serine pathway, as G9A inhibition
or overexpression only affects the intracellular levels of serine
and glycine, and supplemental serine can rescue the prolifera-
tion defect of G9A inhibition (Ding et al., 2013). The underlying
molecular mechanism remains to be determined.
The KDM4C-ATF4 Connection in Transcriptional
Control of Amino Acid Metabolism
ATF4 is a transcriptional master regulator of amino acid meta-
bolism and stress responses (Ameri and Harris, 2008; Baird
and Wek, 2012; Kilberg et al., 2009). The molecular basis for
translational induction of ATF4 in response to amino acid depri-
vation is well defined. The decrease in cellular amino acid levels
results in the accumulation of uncharged tRNA, which then binds
and activates the stress kinase General Control Nonderepressi-
ble 4 (GCN4, also known as EIF2AK4). GCN4, in turn, phosphor-
ylates the a subunit of eukaryotic initiation factor 2 (eIF2a), which
represses global protein synthesis while enhancing the transla-
tion and expression of ATF4 (Harding et al., 2003). ATF4 then
transcriptionally activates genes involved in amino acid synthe-
sis and transport, leading to alleviation of the nutritional stress.
ATF4 can also be transcriptionally activated in response to
amino acid deprivation (Dey et al., 2010; Siu et al., 2002), but
the underlying molecular mechanism is not well understood.
Our study reveals an essential role of KDM4C in maintaining
basal-level expression of ATF4 and in transcriptional activation
of ATF4 in response to serine deprivation. KDM4C binds to the
ATF4 promoter and confers an epigenetically active state by
removing the repressive mark H3K9me3, leading to increased
production of ATF4 mRNA and protein.
Our study further demonstrates that the transcriptional in-
duction of ATF4 is essential for KDM4C to activate the serine
pathway and amino acid transporters. Moreover, we show that
KDM4C interacts with and depends on ATF4 for binding to the
promoters of serine pathway genes, thereby providing a molec-
ular mechanism for targeting KDM4C to these genes. In addition
to acting through ATF4, KDM4C also contributes directly to the
activation of serine pathway genes by generating an epigeneti-
cally active state, as evidenced by the observation that even
under overexpression conditions, ATF4 still requires KDM4C
for maximal levels of gene transcription.
There is evidence suggesting that the ability of KDM4C to
activate amino acid biosynthesis and transport contributes to
its oncogenic activity in promoting cancer cell proliferation and
tumorigenesis since knockdown of PHGDH or ATF4, or inhibition
of mTORC1, completely abrogated the proliferation-enhancing
activity of KDM4C. Together, our investigation reveals a molec-
ular mechanism linking KDM4C-mediated H3K9 demethylation
and ATF4-mediated transcription in reprogramming amino acid
metabolism in cancer cells.516 Cell Reports 14, 506–519, January 26, 2016 ª2016 The AuthorsKDM4C Links Amino Acid Metabolism to Cell Cycle
Control
Cell-cycle progression duplicates the entire cellular content
through anabolic metabolism, ultimately resulting in cell division
that produces two daughter cells. Given the critical role of amino
acid availability in the control of protein production and cell
proliferation, a cell must have effective mechanisms in place
for coordinating amino acid metabolism and cell-cycle pro-
gression. Our findings suggest a KDM4C-dependent epigenetic
mechanism for this coordination. It is well documented that
high KDM4C expression promotes cell proliferation and upre-
gulate the expression of cell-cycle genes (Cloos et al., 2006;
Gregory and Cheung, 2014; Kim et al., 2014; Pedersen et al.,
2014). We confirmed these observations. In addition, our gene
expression profiling revealed that KDM4C transcriptionally acti-
vates FOXM1 and a majority of genes in the FOXM1 pathway.
FOXM1 is a transcription factor that activates the expression of
many mitotic genes and is essential for execution of the mitotic
program (Sadasivam and DeCaprio, 2013). High FOXM1 expres-
sion is a common feature of many types of cancers and is gener-
ally thought to be a key mechanism underlying the high expres-
sion of mitotic genes that is frequently observed in cancers of
poor prognosis (Sadasivam and DeCaprio, 2013). Given that
KDM4C is amplified or overexpressed in a wide range of human
cancers, high KDM4C expression may represent an epigenetic
mechanism for the aberrant activation of the FOXM1-dependent
transcriptional program in cancer development. Thus, KDM4C
coordinates amino acid metabolism and cell-cycle progression
by epigenetically activating the transcription of genes involved
in both cellular processes.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
All cell lines used in this study were originally obtained from ATCC. Cells
were cultured in DMEM (HyClone SH30022, Thermo Scientific) or DME/
F-12 1:1 (HyClone SH30023) supplemented with 10% fetal bovine serum
(FBS) (Atlanta Biologicals S11050). For serine deprivation assays, cells
were cultured in MEM (GIBCO 10095) supplemented with 13 MEM vitamins
(GIBCO 11120), 25 mM D-glucose (Sigma-Aldrich G8769), 0.4 mM serine
(Sigma-Aldrich S4311), and 10% dialyzed FBS (GIBCO 26400), and then
transferred to the same media without serine. Phase contrast images were
captured using an Axio Observer microscope and AxioVision software (Carl
Zeiss MicroImaging).
Immunoblotting
Proteins (20–40 mg) were separated on SDS-polyacrylamide gels, trans-
ferred to nitrocellulose membranes, and probed with primary antibodies
as detailed in the Supplemental Experimental Procedures. Horseradish
peroxidase-conjugated goat anti-mouse and anti-rabbit IgG (Santa Cruz
Biotechnology) were used as secondary antibodies. Proteins were visual-
ized using a SuperSignal West Pico chemiluminescence kit (Pierce) and
quantified with ImageJ (version 1.49o). Films were exposed for various times
for protein quantification within a linear range of detection. For visualization
and quantification with the Odyssey system, goat anti-mouse IRDye 800 or
680 and anti-rabbit IRDye 800 or 680 (LI-COR Biosciences) were used as
secondary antibodies.
Microarray
Total RNA was isolated using Trizol (Invitrogen) from three indepen-
dent samples of BE(2)-C_tetoff_KDM4C cells cultured in the presence or
absence of doxycycline for 6 days. Affymetrix microarray was performed
using the Human Gene 2.0 ST microarray chip. Data were normalized, sig-
nificance determined by ANOVA, and fold change calculated with the Partek
Genomics Suite. GO and PANTHER analyses were performed with DAVID
(Huang et al., 2009) for all differentially expressed genes (R ±1.4-fold,
p < 0.05), and GSEA was performed as described (Subramanian et al.,
2005).
qRT-PCR
Total RNA was isolated from three independent samples using Trizol. Reverse
transcription was performed using SuperScript II Reverse Transcriptase (Invi-
trogen). qRT-PCR was performed using a RT2 SYBR green/Fluorescein PCR
master mix (SABiosciences) on an iQ5 real-time PCR system (Bio-Rad) with
primers against various genes (Table S3). All samples were normalized to b2
microglobulin (B2M) mRNA levels.
ChIP-qPCR
ChIP was performed as described (Ding et al., 2013). For qPCR, two indepen-
dent ChIP samples were analyzed, and each sample was assayed in triplicate
using primers that cover the promoter regions of ATF4, PHGDH, PSAT1, and
HOXC9. Data were presented as percentage of the input chromatin (bound/
input3 100). For ChIP against H3K9methylation marks, data were normalized
to histone H3 content obtained by anti-histone H3 ChIP. ChIP antibodies and
primers are described in the Supplemental Experimental Procedures.
Metabolite Analysis
GC-MS metabolomic analysis was performed as described previously (Ding
et al., 2013). BE(2)-C_tetoff_KDM4C cells were cultured in the presence or
absence of doxycycline for 6 days and collected for metabolite extraction by
80% methanol at 20C. Five biological replicate samples (5 3 106 cells/
sample) were analyzed for each condition.
Statistics
Quantitative data are presented asmean ±SD andwere analyzed for statistical
significance by unpaired, two-tailed Student’s t test or two-way ANOVA using
GraphPad Prism 6.0h for Mac.
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